Drug
Ciclopirox
Ciclopirox: highest development phase Post-Market, developed by Ferrer. 1 trial record tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Ferrer
Trials
| Drug | Phase | Indication |
|---|---|---|
| ciclopirox NCT01646580 | Post-Market | Dermatomycoses |
Latest
No recent events.
Follow Ciclopirox on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.